Qube Research & Technologies (QRT)
SIOX

Qube Research & Technologies (QRT)’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,920
Closed -$26K – 3123
2021
Q3 		$26K Buy
+11,920
New +$25.9K ﹤0.01% 1947

Other funds holding SIOX

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SIOX Position: Q4 2021 in Review

Qube Research & Technologies (QRT) sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q4 2021, closing a stake of 11,920 shares — an estimated $26K sold.

Qube Research & Technologies (QRT) first reported a position in SIOX in Q3 2021 and held it in 1 quarter. The position peaked at $26K in Q3 2021. 48 funds tracked by Wall St. Rank hold SIOX as of Q4 2021.

  • Qube Research & Technologies (QRT) reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 11,920 Sio Gene Therapies Inc. Common Stock shares in Q4 2021, an estimated $26K.
  • Qube Research & Technologies (QRT) first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Sio Gene Therapies Inc. Common Stock position peaked at $26K in Q3 2021.
  • 48 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q4 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2021, filed 1 Feb 2022.